TMDX Trading Analysis - 11/09/2026 10:29 AM โ€” TRU-SENTIMENT

TMDX (TransMedics Group Inc. Common Stock) at $92.08. True Sentiment Bullish, delta 40-60 call 98% / put 2%, call $204,390 vs put $3,660. RSI 69.5.

TRU-SENTIMENT ยท DeltaNeutral

TMDX Trading Analysis - 11/09/2026 10:29 AM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

TMDX (TransMedics Group Inc. Common Stock) at $92.08. True Sentiment Bullish, delta 40-60 call 98% / put 2%, call $204,390 vs put $3,660. RSI 69.5.

Symbol
TMDX
Price
$92.08
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-11-09 10:29:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

From options flow (2026-11-09 10:28):

Call Volume: $204,390.00 (98.20%) Put Volume: $3,660.00 (1.80%) Total: $208,050.00

  • Sentiment: Bullish (call pct 98.2, put pct 1.8).
  • Contracts: 216 calls vs 5 puts; 11 call trades vs 4 put trades.
  • Pure directional conviction strongly bullish near-term.
  • Divergence: technicals show MACD negative / no clear direction per spread advice, yet sentiment bullish.
Note: Options flow shows heavy call buying at Delta 40-60 filter (15 of 902 analyzed).

Key Statistics: TMDX

$92.51 +4.92%
52-Week Range
$60.10 - $156.00
Market Cap
$3.21B
P/E (TTM)
21.00
PEG Ratio
N/A
Beta
2.84
Next Earnings
N/A
Avg Volume
$598,379
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)21.00
EPS (trailing 12 mo)$4.21
Market cap$3.21B
Shares outstanding34.7M

Dividend

Dividend yield0.00%

Risk & range

Beta2.84
52-week low$60.10
52-week high$156.00
Historical volatility89.6%

Ownership & trading

Institutional ownership74.2%
Average daily volume1.1M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

TransMedics Group (TMDX) is a medical technology company focused on organ transplant systems. Recent general-knowledge context includes:

  • TransMedics continued to scale its Organ Care System (OCS) platform, with prior quarters showing strong revenue growth driven by increased adoption in heart and lung transplant centers.
  • The company has historically been volatile around FDA-related news, transplant logistics expansions, and hospital network additions.
  • No specific confirmed earnings date is provided in data, but given fiscal year end of 2025-12-01, a future annual report cycle could act as a catalyst.
  • High beta (2.84) and historical volatility (89.59%) suggest headline-driven moves may be amplified relative to broader markets.
  • Context: The embedded data shows a sharp late-period rally (Nov 6 close 88.17 from ~67 earlier), which may reflect a positive catalyst not captured in the structured dataset but aligned with bullish options flow.

Fundamental Analysis

Based strictly on provided FUNDAMENTALS data:

  • Trailing P/E is 21.00 with trailing EPS of 4.21; PEG ratio is null (not available).
  • Market cap is 3,213,242,340.00 with shares outstanding of 34,734,000.00.
  • Dividend yield is 0.00; no dividend rate or ex-dividend date.
  • Beta is 2.84 (high systematic risk); 52-week range is 60.11 to 156.00.
  • Institutional ownership is 74.21%; average volume is 1,121,000.00.
  • Historical volatility is 89.59%; fiscal year end 2025-12-01.
  • Revenue growth, margins (gross/operating/net), ROE, debt/equity, and FCF are null; analyst target mean and recommendation key are null.
  • Fundamentals show modest valuation (P/E 21.00) vs prior highs (156.00), but lack of margin/return data limits confirmation. Technical rally and bullish sentiment diverge from incomplete fundamental disclosure.

Current Market Position

From minute bars (2026-11-06 09:30 to 2026-11-09 10:00) and daily history:

  • Daily close on 2026-11-06 was 88.17, with intraday high 88.44 and low 76.50; volume 2,380,263 (above 20d avg 738,775).
  • Minute bars show open 79.11 on 11-06, rising to ~82 by 09:50, and later 11-09 bars show open 92.00, dip to 89.93, recover to 92.08 by 10:00.
  • Recent price action: strong breakout from ~67 (11-05) to 88.17 (11-06), then consolidation near 90โ€“92 early 11-09.
Support
$76.50
Resistance
$88.44
Recent High
$92.48
30d High
$88.44
30d Low
$64.64

Technical Analysis

Technical Indicators

Current Price
$88.17
SMA 5
$72.82
SMA 20
$72.29
SMA 50
$79.61
RSI 14
69.47
MACD
-1.77
Signal
-1.42
Hist
-0.35
BB Middle
$72.29
BB Upper
$82.67
BB Lower
$61.91
ATR 14
$5.04
  • Price (88.17) above SMA 5 (72.82), SMA 20 (72.29), SMA 50 (79.61): bullish alignment, no bearish cross.
  • RSI 69.47 near overbought (70) but momentum positive.
  • MACD (-1.77) below signal (-1.42), histogram -0.35: still negative, mild bearish sub-signal within uptrend.
  • Bollinger: price above upper band (82.67) = expansion, statistically extended.
  • 30d range: high 88.44, low 64.64; price at top 99%+ of range.

True Sentiment Analysis (Delta 40-60 Options)

From options flow (2026-11-09 10:28):

Call Volume: $204,390.00 (98.20%) Put Volume: $3,660.00 (1.80%) Total: $208,050.00

  • Sentiment: Bullish (call pct 98.2, put pct 1.8).
  • Contracts: 216 calls vs 5 puts; 11 call trades vs 4 put trades.
  • Pure directional conviction strongly bullish near-term.
  • Divergence: technicals show MACD negative / no clear direction per spread advice, yet sentiment bullish.
Note: Options flow shows heavy call buying at Delta 40-60 filter (15 of 902 analyzed).

Key Price Levels (Observational Only)

Support (Daily Low 11-06)
$76.50
Resistance (30d High)
$88.44
SMA 50
$79.61
BB Upper
$82.67
30d Low
$64.64

Interactive charts load with JavaScript. This text is the crawlable summary.